Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. Colombel JF, Hisamatsu T, Atreya R, Bresso F, et al. Clin Gastroenterol Hepatol 2024 Mar 14:S1542-3565(24)00254.

Read + Share

Amedeo Smart

Independent Medical Education

Colombel JF, Hisamatsu T, Atreya R, Bresso F, et al. Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. Clin Gastroenterol Hepatol 2024 Mar 14:S1542-3565(24)00254.
PMID: 38492903